[1] Mei L,Song P,Kokudo N,et al.Current situation and prospects of newborn screening and treatment for Phenylketonuria in China—compared with the current situation in the United States,UK and Japan[J].Intractable Rare Dis Res,2013,2(4):106. [2] Bosch AM,Tybout W,Van Spronsen FJ,et al.The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria[J].J Inherit Metab Dis,2007,30(1):29-34. [3] Simon E,Schwarz M,Roos J,et al.Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU)[J].Health Qual Life Outcomes,2008,6(1):25-43. [4] Cazzorla C,Cegolon L,Burlina AP,et al.Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria[J].BMC Public Health,2014,14(1):1243. [5] Varni JW,Burwinkle TM,Seid M,et al.The PedsQL 4.0 as a pediatric population health measure:feadibility,reliability,and validity[J].Ambul Pediatr,2003,3(6):329-341. [6] Hoeksma M,Reijingoud DJ,Pruim J,et al.Phenyketonuria: high plasma phenylalanine decreases cerebral protein synthesis [J].Mol Genet Metab,2009,96(4):177-182. [7] 李松,孙巧玲,周怡,等.安徽省104例苯丙酮尿症儿童生活质量及其影响因素研究[J].中国当代儿科杂志,2016,18(8):702-706. [8] Thimm E,Schmidt LE,Heldt K,et al.Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents[J].J Inherit Metab Dis,2013,36(5):767-772. [9] Douglas TD,Ramakrishnan U,Kable JA,et al.Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride[J].Health Qual Life Outcomes,2013,11(1):1-10. [10] Ziesch B,Weigel J,Thiele A,et al.Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment,metabolic control,and quality of life[J].J InheritMetab Dis,2012,35(6):983-992. |